3.27 WEIR Lymphomas II Flashcards

1
Q

What 4 major factors must a doctor consider when he/she decides if cure is possible for a patient with lymphoma?

A

Tumor Histology

Tumor Stage

Condition of patient

Avaliable Therapies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name the most common indolent lymphoma. Aggressive lymphoma?

A

Indolent: Follicular lymhoma

Aggressive: Diffuse Large B cell lymphoma

Very Aggressive: Burkitt’s (t(8;14))

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Be able to stage a patient with lymphoma

A

-Stage I: single node or lymphoid structure

–Stage IE: extranodal is the sole site of involvment

  • Stage II: Two or more lymph regions one side diaphragm
  • Stage III: both sides of diaphragm

Stage IV: Lymph node involvement plus an extranodal site of involvement

How to stage: history and exam, CAT scan chest, abdomen and pelvis, BM aspirate and biopsy w/ flow, Gallium or PET scan, Chemistries: CBC, LDH and CSF is high risk disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the major treatment decision differences between indolent and aggressive lymphomas?

A

Indolent: (1) Higher stage (2) Slower progression (3) Response to simple therapies (4) incurable except with stage 1-2 (allogenic transplant may cure) (5) survival independent of early treatment (6) treat when symptomatic

Aggressive: (1) often lower stage (2) rapid progression (3) requires complex therpies (4) potential cure** (5) early therapy required, treat right away

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Understand the mechanism and sites of action of rituximab and ibrutinib.

A

Rituximab: CD20: increased survival when added to CHOP

Ibrutinib: Bruton Tyrosine Kinase Inhibitior (Bcell Refractory disease)

-Prevents Kinase to eventual activation of NFkB which will induce transcription of survival signals to avoid apoptosis

Other drugs mentioned:

Alemtuzumab (CD52, CLL and T-cell leukemia)

Brentuximab vedatin: CD30 (Hodgkin and CD30+ T cell lymphomas)

Inotuzumab ozogamicin: CD22

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the name of the most common cutaneous lymphoma and what cell can you find in the blood in some of these patients?

A

Mycosis Fungoides

-T cell derived (usually indolent)

Stage 4: seizry syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a common complication of radiation therapy in young Hodgkin’s Disease women?

A
  • They are at an increased risk for breast cancer w/n 30yrs of treatment, some showing up as early as 15 yrs
  • Reconsidering chemo therapy for these patient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Name two complications of CLL.

A
  • Hypogammaglobulinemia: reoccuring infections
  • Autoimmune cytopenias
  • Anemia
  • Splenomegaly
  • Lymphadenopathy
  • Lymphocytosis
  • Often asymptomatic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name two poor prognostic chromosome abnormalities in CLL.

A
  • High Stage
  • Increased lymphocyte doubling time
  • Deletion 17p, 11q23 (p53)
  • Unmutated VH gene, ZAP-70, CD38
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When is BMT used in Lymphomas?

A
  • Indolent lymphomas that are stage I or II
  • Aggressive lymphomas that relapse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly